Adjuvant chemotherapy for patients with rectal cancer - will the controversy be resolved? - Wikidata - wikimedia - TriplyDB

Adjuvant chemotherapy for patients with rectal cancer - will the controversy be resolved?

Adjuvant chemotherapy for patients with rectal cancer - will the controversy be resolved?

http://www.wikidata.org/entity/Q53579641

about

On a prolonged interval between rectal cancer (chemo)radiotherapy and surgery.Prognostic significance of PLA2G4C gene polymorphism in patients with stage II colorectal cancer.

P2860

Q37715201-A6EE572E-6F96-43DA-B86C-AE7027166EBB Q41366924-D34DB568-A81C-4CFB-8C07-4F431F1E633C

P2860

Adjuvant chemotherapy for patients with rectal cancer - will the controversy be resolved?

http://www.wikidata.org/entity/Q53579641

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Adjuvant chemotherapy for patients with rectal cancer - will the controversy be resolved?

@en

Adjuvant chemotherapy for patients with rectal cancer - will the controversy be resolved?

@nl

type

label

Adjuvant chemotherapy for patients with rectal cancer - will the controversy be resolved?

@en

Adjuvant chemotherapy for patients with rectal cancer - will the controversy be resolved?

@nl

prefLabel

Adjuvant chemotherapy for patients with rectal cancer - will the controversy be resolved?

@en

Adjuvant chemotherapy for patients with rectal cancer - will the controversy be resolved?

@nl

P1433

Q53579641-625212ED-12EF-4643-A6BF-44577B2835D5

P1476

Q53579641-C59EE38C-DEDD-4482-99F8-FD12566FED25

P2860

Q53579641-212F9F7F-5A06-48F8-846F-28387AEBE47F

Q53579641-2D084C44-623C-4FC6-AC0A-A04797A2B014

Q53579641-3064B0D2-EF54-4AEE-BAC5-97847D912759

Q53579641-3E938A2D-2D87-4482-9322-ACE22316BB6E

Q53579641-400A90DC-591D-4480-8FCC-E47AF2C88E69

Q53579641-48C9F372-BD74-462B-A00A-2C66A4B96485

Q53579641-50988E24-D29C-4DA8-B64C-7AD911C174B6

Q53579641-58270A8B-FF71-48D4-A540-B5AB295378BF

Q53579641-6311D340-7FF4-43A7-996E-1395BF338415

Q53579641-6ADC4AF7-65AB-4D02-9CA3-8B4A24F33FD1

P304

Q53579641-9933522E-83D9-42B0-A8DF-4EBC20B8088D

P31

Q53579641-11D17A75-9DC2-412A-B2E4-DB42F3538472

Q53579641-5d954e4a-19c0-4427-b894-e8949746135e

P356

Q53579641-D9AA725D-DA6E-4636-83A2-80247CC38705

P433

Q53579641-42C35A67-1480-4D6C-94C3-72524BDB6C1D

P478

Q53579641-B3DCA59E-771A-4EF1-B52F-6CA24CFB67F3

P50

Q53579641-0E8EF636-740F-46B7-A1BE-B422FE65EE51

P577

Q53579641-7B79DA06-A652-4EAD-B052-B93E9A815375

P698

Q53579641-CD74732D-0B18-4FC8-9825-50595B2E6421

P921

Q53579641-49511DF1-FE33-4DB1-AF20-2985714D08A5

P356

0284186X.2015.1024331

P1433

Acta Oncologica

P1476

Adjuvant chemotherapy for patients with rectal cancer - will the controversy be resolved?

@en

P2860

The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis.

The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 mont

Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data.

Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials.

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.

Multidisciplinary treatment of patients with rectal cancer: Development during the past decades and plans for the future.

Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial.

Adjuvant systemic chemotherapy for Stage II and III colon cancer after complete resection: an updated practice guideline.

Risk of recurrence in patients with colon cancer stage II and III: a systematic review and meta-analysis of recent literature.

P304

433-436

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/0284186X.2015.1024331

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

Bengt Glimelius

P577

2015-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25783749

http://www.w3.org/2001/XMLSchema#string

P921